Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Jamie Dimon warns Iran war could drive inflation, interest rates higher - 2IDF says up to 90% of Iran’s weapons industry could be hit within days
- 37 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
- 4Virtual Route d: A Survey of \Exploring On the web Stages\ Web Administration
- 5'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
- WHO issues guidance on GLP-1 drugs for obesity
- 7 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide
- German Court Rejects Bid To Force BMW and Mercedes-Benz To Stop Selling New Combustion-Engine Cars After 2030
- Crime boss Steven Lyons set to be deported from Bali to Spain
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- South Korea launches Earth-observation satellite on homegrown Nuri rocket
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Revealing the Specialty of Food Matching: Improving Culinary Encounters
- CVS forecasts 2026 profit above estimates on strong performance
